A recent study conducted by Cannabis Public Policy Consulting (CPPC) at the request of the Utah Department of Agriculture and Food (UDAF) has shed light on an alarming trend among medical cannabis patients in the state. Despite the existence of state-licensed retailers, approximately 60% of Utah’s registered medical cannabis patients continue to obtain their cannabis products from unregulated sources.
In-State Cost Challenges
The study, which surveyed nearly 200 medical cannabis patients, revealed that while monthly prices for medical cannabis products in Utah rank among the lowest ten in the United States, a significant portion of patients still seek alternatives due to the in-state cost. Dr. Brandon Forsyth, UDAF Director of Industrial Hemp and Medical Cannabis, emphasized the importance of evaluating the state’s medical cannabis program to ensure adequate patient access to essential medicine. “I am proud to see that overall, patients can legally access their medication within the state at a reasonable cost compared to other medical cannabis markets,” said Forsyth.
Supply and Demand Dynamics
Among the patients surveyed, 58% reported that there was plenty of medical cannabis supply within the state, while 41% indicated that the supply was limited or very limited. These dynamics highlight the delicate balance between meeting patient needs and maintaining a regulated market. With approximately 71,850 registered medical cannabis patients in Utah, addressing supply challenges remains a priority for policymakers and industry stakeholders.
The Road Ahead
As Utah’s medical cannabis program continues to evolve, policymakers must address the following key areas:
- Affordability: While Utah’s prices are competitive, efforts to further reduce costs could discourage patients from seeking unregulated alternatives.
- Supply Chain Optimization: Ensuring a consistent and reliable supply of medical cannabis products is crucial to meeting patient demand.
- Education and Awareness: Educating patients about the benefits of obtaining cannabis from regulated sources can help shift behavior away from the illicit market.
The study serves as a wake-up call for Utah’s cannabis industry, urging stakeholders to collaborate and create a sustainable, patient-centric system that prioritizes safety, affordability, and accessibility.